April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Subretinal AAV2/8 Is More Efficient At Targeting The Outer Reina Of The Cat Than AAV2/5
Author Affiliations & Notes
  • Andrea L. Minella
    Small Animal Clinical Sciences, MSU College of Veterinary Medicine, East Lansing, Michigan
  • Joshua T. Bartoe
    Small Animal Clinical Sciences, MSU College of Veterinary Medicine, East Lansing, Michigan
  • Freya M. Mowat
    Small Animal Clinical Sciences, MSU College of Veterinary Medicine, East Lansing, Michigan
  • Kristina Narfstrom
    Department of Veterinary Medicine and Surgery, University of Missouri-Columbia, Columbia, Missouri
  • Jean Bennett
    F M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania
  • Simon M. Petersen-Jones
    Small Animal Clinical Sciences, MSU College of Veterinary Medicine, East Lansing, Michigan
  • Footnotes
    Commercial Relationships  Andrea L. Minella, None; Joshua T. Bartoe, None; Freya M. Mowat, None; Kristina Narfstrom, None; Jean Bennett, None; Simon M. Petersen-Jones, None
  • Footnotes
    Support  Grousbeck Family Foundation, Glassen Foundation
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3325. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andrea L. Minella, Joshua T. Bartoe, Freya M. Mowat, Kristina Narfstrom, Jean Bennett, Simon M. Petersen-Jones; Subretinal AAV2/8 Is More Efficient At Targeting The Outer Reina Of The Cat Than AAV2/5. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3325.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Adeno-associated viral (AAV) vectors are the delivery system of choice for retinal gene therapy. They are effective in a variety of species including rodents, dogs and primates. The cellular tropism and speed and strength of transgene expression of AAV vector systems can be varied by utilizing different capsid serotypes. Recently the gene mutations underlying two Leber congenital amaurosis (LCA) cat models have been identified. One is due to a mutation in the CEP290 gene and the other a mutation in CRX. These mutant cats are ideal large animal models for preclinical gene therapy studies for these forms of LCA in humans. The aim of this study was to investigate the speed of transgene expression and cellular tropism of two commonly used AAV serotypes (AAV2/5 and AAV2/8) in the cat.

Methods: : AAV2/5 and AAV2/8 vectors expressing green fluorescent protein (GFP) under control of the CMV promoter were prepared and diluted to 5 x 1011 vg/ml. Four wild-type young adult cats were used. Following 3-port pars plana vitrectomy the right eye was injected subretinally with 200µl AAV2/5 and the left eye with 200µl of AAV2/8. Ophthalmic examination and color and fluorescent fundus photography were performed regularly. Following euthanasia eyes were fixed in paraformaldehyde and processed for cryosectioning and immunohistochemistry.

Results: : GFP expression was detected in the AAV2/8 injected eyes 2 days following treatment. Fluorescence in the AAV2/5 injected eyes developed more slowly and was not as strong as that in the AAV2/8 injected eyes. The outer retina was transduced in the injected areas by both serotypes.

Conclusions: : AAV2/5 and AAV2/8 vectors are efficient at transducing the feline outer retina with a similar tropism to that described in other species. AAV2/8 resulted in faster and stronger transgene expression than a similar titer and dose of AAV2/5. These results show that AAV vectors can be utilized in the cat for outer retinal gene therapy.

Keywords: gene transfer/gene therapy • genetics • immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×